139 related articles for article (PubMed ID: 3767344)
1. Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.
Chan J; Luft BJ
Antimicrob Agents Chemother; 1986 Aug; 30(2):323-4. PubMed ID: 3767344
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice.
Luft BJ
Eur J Clin Microbiol; 1987 Aug; 6(4):479-81. PubMed ID: 3665901
[TBL] [Abstract][Full Text] [Related]
3. Activity of roxithromycin against Toxoplasma gondii in murine models.
Chang HR; Pechère JC
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():69-74. PubMed ID: 3429388
[TBL] [Abstract][Full Text] [Related]
4. In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii.
Hofflin JM; Remington JS
Antimicrob Agents Chemother; 1987 Feb; 31(2):346-8. PubMed ID: 3105452
[TBL] [Abstract][Full Text] [Related]
5. Effect of roxithromycin on acute toxoplasmosis in mice.
Chang HR; Pechere JC
Antimicrob Agents Chemother; 1987 Jul; 31(7):1147-9. PubMed ID: 3662475
[TBL] [Abstract][Full Text] [Related]
6. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
Romand S; Bryskier A; Moutot M; Derouin F
J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
[TBL] [Abstract][Full Text] [Related]
7. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
Araujo FG; Shepard RM; Remington JS
Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
[TBL] [Abstract][Full Text] [Related]
8. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
9. Activity of spiramycin against Toxoplasma gondii in vitro, in experimental infections and in human infection.
Chang HR; Pechère JC
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():87-92. PubMed ID: 3182450
[TBL] [Abstract][Full Text] [Related]
10. [Effects of clindamycin and josamycin in experimental Toxoplasma gondii infections].
Terragna A; Canessa A; Terragna FM; Corradino L
Minerva Med; 1984 Oct; 75(39):2305-8. PubMed ID: 6504394
[TBL] [Abstract][Full Text] [Related]
11. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Brun-Pascaud M; Chau F; Derouin F; Girard PM
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.
Nguyen BT; Stadtsbaeder S
Br J Pharmacol; 1983 Aug; 79(4):923-8. PubMed ID: 6606459
[TBL] [Abstract][Full Text] [Related]
13. The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection.
Araujo FG; Khan AA; Slifer TL; Bryskier A; Remington JS
Antimicrob Agents Chemother; 1997 Oct; 41(10):2137-40. PubMed ID: 9333038
[TBL] [Abstract][Full Text] [Related]
14. Rifapentine is active in vitro and in vivo against Toxoplasma gondii.
Araujo FG; Khan AA; Remington JS
Antimicrob Agents Chemother; 1996 Jun; 40(6):1335-7. PubMed ID: 8725996
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.
Chang HR; Pechère JC
Antimicrob Agents Chemother; 1988 Apr; 32(4):524-9. PubMed ID: 2837140
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of experimental Toxoplasma gondii (RH strain) infection.
Gill HS; Prakash O
Indian J Med Res; 1970 Sep; 58(9):1197-202. PubMed ID: 4994796
[No Abstract] [Full Text] [Related]
17. Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.
Chang HR; Rudareanu FC; Pechère JC
J Antimicrob Chemother; 1988 Sep; 22(3):359-61. PubMed ID: 2972671
[TBL] [Abstract][Full Text] [Related]
18. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
19. Roxithromycin (RU 965): effective therapy for experimental syphilis infection in rabbits.
Lukehart SA; Baker-Zander SA
Antimicrob Agents Chemother; 1987 Feb; 31(2):187-90. PubMed ID: 3551828
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the therapeutics of experimental toxoplasmosis. I. Effect of acetylspiramycin and spiramycin on the intracardiac Toxoplasma multiplication in mice infected with Toxoplasma gondii (author's transl)].
Espinas FM; Odakura Y; Suzuki N; Sasaki H
Jpn J Antibiot; 1981 Aug; 34(8):1141-7. PubMed ID: 7321193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
